A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients
Clinical trial NCT01567735 · COMPLETED
Trial details
- NCT number
- NCT01567735
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-27
- Primary completion
- 2014-03-20
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.